Skip to main content

Table 2 Summary of standards of care by country (year 2009)

From: The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya

Malaria severity Antimalarial drugs Other drugs (non-anti-malarial) Average length of stay Other treatments
Ghana
UM Artesunate-amodiaquine (80%); artemether-lumefantrine (20%) Paracetamol (100%); promethazine (20%) 0 -
MO Quinine (100%) Paracetamol (100%); phenobarbital (10%) 7 -
MO + SA Quinine (100%) Gentamicin (10%); cotrimoxazole (10%) 10 Iron supplementation (100%); blood transfusion (50%)
CerM Quinine (80%); artemether lumefantrine (20%) Paracetamol (80%); hydrocortison (5%); phenobarbital (50%) 7  
CerM + NS Quinine (80%); artemether lumefantrine (20%) Paracetamol (80%); hydrocortison (5%); phenobarbital (50%) 12 Rehabilitation visit every 10 days for 1 year
Tanzania
UM Artesunate-Amodiaquine (75%); Quinine (25%) Paracetamol (100%); promethazine (20%) 0 -
MO Quinine (100%) Paracetamol (100%) 7 -
MO + SA Quinine (100%) Gentamicin (10%); cotrimoxazole (10%) 7 Iron supplementation (100%); blood transfusion (50%)
CerM Quinine (100%) Paracetamol (60%); phenobarbital (30%) 7  
CerM + NS Quinine (100%) Paracetamol (60%); phenobarbital (30%) 10 Rehabilitation visit every 15 days for 1 year
Kenya
UM Artesunate-amodiaquine (75%); artemether-lumefantrine (25%) Paracetamol (100%); promethazine (20%) 0 -
MO Quinine (80%); artemether lumefantrine (20%) Paracetamol (100%); phenobarbital (10%) 7 -
MO + SA Quinine (80%); artemether lumefantrine (20%) Gentamicin (10%); cotrimoxazole (10%) 9 Iron supplementation (100%); blood transfusion (50%)
CerM Quinine (80%); artemether lumefantrine (20%) Paracetamol (70%); phenobarbital (30%) 7  
CerM + NS Quinine (80%); artemether lumefantrine (20%) Paracetamol (70%); hydrocortison (5%); phenobarbital (30%) 10 Rehabilitation visit every 15 days for 1 year
  1. Notes: UM uncomplicated malaria, MO malaria hospitalization, SA severe anemia, CerM cerebral malaria, CerM + NS cerebral malaria and neurological sequelae. In brackets, the proportion of cases receiving treatment.